Home/ICT/Artificial Intelligence/Zero-Shot and Few-Shot Learning Market

Zero-Shot and Few-Shot Learning Market - Strategic Insights and Forecasts (2025-2030)

Zero-shot and few-shot learning market analysis highlighting the integration of large language models and multimodal AI systems for advanced decision-making.

$3,950
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

📞

Your data is secure. We do not share information with any third party.

Zero-Shot and Few-Shot Learning Market Report

Report IDKSI061617576
PublishedFeb 2026
Pages144
FormatPDF, Excel, PPT, Dashboard

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Frequently Asked Questions

The Zero-Shot and Few-Shot Learning Market is projected to expand at a significant CAGR over the forecast period (2025-2030). This growth is primarily driven by growing advancements in generative AI and large language models, alongside the increasing demand for scalability and cost-effectiveness in AI development. Organizations are also motivated by the reduced dependence on large labelled datasets and the ability to enhance decision-making with limited data.

The few-shot learning segment is expected to hold a significant share in the zero-shot and few-shot learning market. This is attributed to its ability to utilize a small amount of labelled data for fine-tuning models, which often results in superior accuracy compared to zero-shot learning in various tasks. Its versatility and scalability make it highly suitable for diverse applications across healthcare, retail, and finance.

The natural language processing (NLP) segment is a major growth driver in the market, largely due to advancements in large language models that integrate zero-shot and few-shot learning capabilities. Following NLP, the computer vision and healthcare diagnostics segments are also expected to grow at a substantial pace, driven by their utilization in autonomous vehicles and for improving accuracy in disease diagnosis, respectively.

The healthcare and pharmaceutical segment is projected to hold a substantial share within the end-user market. This is primarily due to the inherent limitations of data related to rare diseases and new drug discovery, combined with the high cost and time-consuming nature of collecting large datasets, which makes zero-shot and few-shot learning solutions highly advantageous for this sector.

The Europe region is predicted to witness considerable growth in the Zero-Shot and Few-Shot Learning Market. While specific detailed drivers for Europe are not elaborated in the provided content, its projected considerable growth indicates strong regional adoption and investment in these advanced AI technologies for various applications.

Key factors encouraging adoption and influencing market strategy include the ability of these learning models to perform tasks with minimal labelled training data, thereby reducing dependence on extensive datasets. Additionally, rising demand for cost-efficient AI development, strengthening data privacy regulations that promote minimal personal data usage, and the improved adaptability of models across diverse real-world applications due to generative AI advancements are crucial considerations for organizations.

Need data specifically for your business?Request Custom Research →

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon